California Public Employees Retirement System’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.6M Buy
+50,879
New +$8.79M 0.01% 919
2021
Q2
Sell
-51,584
Closed -$2.92M 1692
2021
Q1
$2.92M Sell
51,584
-8,773
-15% -$617K ﹤0.01% 1766
2020
Q4
$4.92M Sell
60,357
-3,602
-6% -$269K ﹤0.01% 1439
2020
Q3
$4.56M Buy
63,959
+1,600
+3% +$125K ﹤0.01% 1298
2020
Q2
$5.13M Buy
62,359
+4,217
+7% +$325K 0.01% 1188
2020
Q1
$3.42M Buy
58,142
+9,200
+19% +$750K ﹤0.01% 1254
2019
Q4
$5.06M Buy
48,942
+21,808
+80% +$881K ﹤0.01% 1442
2019
Q3
$549K Buy
27,134
+3,692
+16% +$94.9K ﹤0.01% 2527
2019
Q2
$604K Buy
+23,442
New +$470K ﹤0.01% 2447

Other funds holding AXSM

California Public Employees Retirement System's AXSM Position: Q1 2026 in Review

California Public Employees Retirement System opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 50,879 shares worth $8.6M. The stake represents 0.01% of the portfolio and ranks #919 among its holdings. This is a return to the name: California Public Employees Retirement System previously reported a position in AXSM as recently as Q1 2021.

California Public Employees Retirement System first reported a position in AXSM in Q2 2019 and has held it in 9 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • California Public Employees Retirement System held 50,879 shares of Axsome Therapeutics worth $8.6M as of Q1 2026.
  • Axsome Therapeutics was a new California Public Employees Retirement System position in Q1 2026.
  • Axsome Therapeutics made up 0.01% of California Public Employees Retirement System's portfolio in Q1 2026, its #919 holding.
  • California Public Employees Retirement System first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 9 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on California Public Employees Retirement System's 13F filing for Q1 2026, filed 6 May 2026.